Abstract:fi2AR is an important drug target protein involving many diseases. Biased drugs induce specific signaling and provide additional clinical utility to optimize fi2AR-based therapies. However, the biased signaling mechanism has not been elucidated. Motivated by the issue, we chose four agonists with divergent bias (balanced agonist, G-protein-biased agonist, and fi-arrestin-biased agonists) and utilized Gaussian accelerated molecular dynamics simulation coupled with a dynamic network to probe the molecular mechanisms of distinct biased activation induced by the structural differences between the four agonists. Our simulations reveal that the G-protein-biased agonist induces an open conformation with the outward shifts of TM6 and TM7 for the intracellular domain, which will be beneficial to couple G protein. In contrast, the fi- arrestin-biased agonists regulate an occluded conformation with a slightly outward movement of TM6 and an inward shift of TM7, which should favor fi-arrestin signaling. The balanced agonist does not induce an observable outward shift for TM6 but, along with a slight tilt for TM7, leads to an inactive-like conformation. In addition, our results reveal the first time that ICL3 presents specific conformations with different agonists. The G-protein-biased agonist drives ICL3 to open so that the G protein-binding pocket can be available, while the fi-arrestin-biased agonists induce ICL3 to form a closed conformation with a stable local a-helix. MM/PBSA analysis further reveals that the hydroxyl groups in the resorcinol of the G-protein-biased agonist form strong interactions with Y5.38 and S5.42, thus preventing tilting of the TM5 extracellular end. The catechol of the balanced agonist and the fi-arrestin-biased ones induces the rearrangement of two hydrophobic residues F6.52 and W6.48. However, different from the balanced agonist, the ethyl substituent of fi-arrestin-biased agonists forms additional hydrophobic interactions with W6.48 and F6.51 after the rearrangement, which should contribute to the fi-arrestin bias. The shortest pathway analysis further reveals that the three residues Y7.43, N7.45, and N7.49 are crucial for allosterically regulating G-protein-biased signaling, while the two residues W6.48 and F6.44 make an important contribution to regulate fi-arrestin-biased signaling. For the balanced agonist NE, the allosteric regulation pathway simultaneously involves the residue associated with G-protein-biased signaling like S5.46 and the residues related to fi-arrestin-biased signaling like W6.48 and F6.44, thus producing unbiased signaling. The observations could advance our understanding of the biased activation mechanism on class A GPCRs and provide a useful guideline for the design of biased drugs.

Epitope-Tagged Knockin Mice Reveal Ligand-Selective Internalization That Explains Differential Desensitization Of Alpha2-Adrenergic Responses In Native Sympathetic Neurons

Epitope-Tagged Receptor Knock-In Mice Reveal That Differential Desensitization Of Alpha(2)-Adrenergic Responses Is Because Of Ligand-Selective Internalization

Single Hormone or Synthetic Agonist Induces Gs/Gi Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths.

Identification Of Distinct Carboxyl-Terminal Domains Mediating Internalization And Down-Regulation Of The Hamster Alpha(1b) Adrenergic Receptor

Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics

Distinct binding conformations of epinephrine with α- and β-adrenergic receptors

Structural insights into ligand recognition, activation, and signaling of the α 2A adrenergic receptor

A mutation in the hamster alpha(1B)-adrenergic receptor that differentiates two steps in the pathway of receptor internalization

Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonists

Potency of Catecholamines and Other L-Tyrosine Derivatives at the Cloned Mouse Adrenergic Receptors

Sustained Norepinephrine Stimulation Induces Different Regulation of Expression in Three Α1-Adrenoceptor Subtypes

Stimulation of Α2-Adrenoceptors Suppresses Excitatory Synaptic Transmission in the Medial Prefrontal Cortex of Rat

Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors

Regulation of Α2a Adrenergic Receptor Trafficking and Signaling by Amyloid Precursor Protein

Haplotype Polymorphism in the Alpha-2B-Adrenergic Receptor Gene Influences Response Inhibition in a Large Chinese Sample

Probing the Mechanism of Receptor Activity–Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists

Subtypes Optimizes -Adrenergic Modulation of Cardiac Contractility

Activation of Α2 Adrenoceptors Inhibited NMDA Receptor-Mediated Nociceptive Transmission in Spinal Dorsal Horn of Mice with Inflammatory Pain

Modeling The Interactions Between Alpha(1)-Adrenergic Receptors And Their Antagonists

Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms

Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the 2-Adrenergic Receptor